DCLK1 and neoplasm: By performing multivariate analysis to control for relevant clinical factors including age, gender, stage, T, N, M, and tumor location, we found that DCLK1 is an independent factor which can be used to predict poor DSS (p = 0.009, Figure 1C and Table S3) and PFI (p = 0.024, Table S4), but not OS (p = 0.18, Table S4) in CRC.